ASW
N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide
Created: | 2012-07-25 |
Last modified: | 2021-03-01 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 47 |
Chiral Atom Count | 0 |
Bond Count | 50 |
Aromatic Bond Count | 22 |
Chemical Component Summary | |
---|---|
Name | N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide |
Synonyms | Amsacrine |
Systematic Name (OpenEye OEToolkits) | N-[4-(acridin-9-ylamino)-3-methoxy-phenyl]methanesulfonamide |
Formula | C21 H19 N3 O3 S |
Molecular Weight | 393.459 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | O=S(=O)(Nc1ccc(c(OC)c1)Nc2c4c(nc3c2cccc3)cccc4)C |
SMILES | CACTVS | 3.370 | COc1cc(N[S](C)(=O)=O)ccc1Nc2c3ccccc3nc4ccccc24 |
SMILES | OpenEye OEToolkits | 1.7.6 | COc1cc(ccc1Nc2c3ccccc3nc4c2cccc4)NS(=O)(=O)C |
Canonical SMILES | CACTVS | 3.370 | COc1cc(N[S](C)(=O)=O)ccc1Nc2c3ccccc3nc4ccccc24 |
Canonical SMILES | OpenEye OEToolkits | 1.7.6 | COc1cc(ccc1Nc2c3ccccc3nc4c2cccc4)NS(=O)(=O)C |
InChI | InChI | 1.03 | InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23) |
InChIKey | InChI | 1.03 | XCPGHVQEEXUHNC-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB00276 |
---|---|
Name | Amsacrine |
Groups |
|
Description | Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. |
Synonyms |
|
Brand Names | Amsa Pd |
Indication | For treatment of acute myeloid leukaemia. |
Categories |
|
ATC-Code | L01XX01 |
CAS number | 51264-14-3 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
DNA | - | unknown | intercalation |
DNA topoisomerase 2-alpha | MEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTY... | unknown | inhibitor |
Potassium voltage-gated channel subfamily H member 2 | MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCE... | unknown | inhibitor |
Alpha-1-acid glycoprotein 1 | MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAF... | unknown | |
Serum albumin | MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA... | unknown | |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL43 |
PubChem | 2179 |
ChEMBL | CHEMBL43 |
ChEBI | CHEBI:2687 |
CCDC/CSD | CIRTIG, CIRTIG01, ACRMSA |